{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:07:08Z","timestamp":1789056428140,"version":"build-2803163510"},"reference-count":84,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH GM082946"],"award-info":[{"award-number":["NIH GM082946"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omta.2026.201770","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:06:31Z","timestamp":1780963591000},"page":"201770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intracellular trafficking and nuclear compartmentalization of AAV gene delivery"],"prefix":"10.1016","volume":"34","author":[{"given":"Tarun E.","family":"Hutchinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat Emanuel","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Yu","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Hsi-Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Mietzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4986-7505","authenticated-orcid":false,"given":"Antonette","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2792-935X","authenticated-orcid":false,"given":"Robert","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2026.201770_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/bmb\/ldy005","article-title":"Retinal gene therapy","volume":"126","author":"Kumaran","year":"2018","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.omta.2026.201770_bib2","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s40265-019-01162-5","article-title":"Onasemnogene Abeparvovec: First Global Approval","volume":"79","author":"Hoy","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.omta.2026.201770_bib3","first-page":"64","article-title":"Hemgenix\u00ae - Faktor IX wird aktiviert","volume":"166","author":"Gr\u00e4tzel von Gr\u00e4tz","year":"2024","journal-title":"MMW - Fortschritte Med."},{"key":"10.1016\/j.omta.2026.201770_bib4","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1182\/bloodadvances.2023011847","article-title":"Roctavian gene therapy for hemophilia A","volume":"8","author":"Samelson-Jones","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.omta.2026.201770_bib5","first-page":"1","article-title":"Adeno-associated virus biology","volume":"807","author":"Weitzman","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omta.2026.201770_bib6","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1128\/jvi.62.9.3356-3363.1988","article-title":"Alternate mRNA splicing is required for synthesis of adeno-associated virus VP1 capsid protein","volume":"62","author":"Trempe","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib8","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.1128\/JVI.00580-07","article-title":"Surface-exposed adeno-associated virus Vp1-NLS capsid fusion protein rescues infectivity of noninfectious wild-type Vp2\/Vp3 and Vp3-only capsids but not that of fivefold pore mutant virions","volume":"81","author":"Grieger","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virol.2011.08.011","article-title":"Structure-function analysis of receptor-binding in adeno-associated virus serotype 6 (AAV-6)","volume":"420","author":"Xie","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.omta.2026.201770_bib10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/4768","article-title":"AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection","volume":"5","author":"Summerford","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2026.201770_bib11","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1128\/JVI.00878-06","article-title":"The 37\/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9","volume":"80","author":"Akache","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.chom.2011.10.014","article-title":"Adeno-associated virus 2 infection requires endocytosis through the CLIC\/GEEC pathway","volume":"10","author":"Nonnenmacher","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.omta.2026.201770_bib13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41434-021-00252-y","article-title":"Correction: Intracellular trafficking of adeno-associated virus (AAV) vectors: challenges and future directions","volume":"28","author":"Riyad","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2026.201770_bib14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature16465","article-title":"An essential receptor for adeno-associated virus infection","volume":"530","author":"Pillay","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201770_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00391-17","article-title":"Adeno-associated Virus (AAV) Serotypes Have Distinctive Interactions with Domains of the Cellular AAV Receptor","volume":"91","author":"Pillay","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib16","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1128\/jvi.76.5.2340-2349.2002","article-title":"Endocytosis of adeno-associated virus type 5 leads to accumulation of virus particles in the Golgi compartment","volume":"76","author":"Bantel-Schaal","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1089\/hum.2016.008","article-title":"Disruption of Microtubules Post-Virus Entry Enhances Adeno-Associated Virus Vector Transduction","volume":"27","author":"Xiao","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2026.201770_bib18","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1128\/JVI.02660-13","article-title":"Recombinant adeno-associated virus utilizes host cell nuclear import machinery to enter the nucleus","volume":"88","author":"Nicolson","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib19","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1128\/jvi.70.5.3227-3234.1996","article-title":"Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors","volume":"70","author":"Ferrari","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib20","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1128\/JVI.03419-13","article-title":"Highly divergent integration profile of adeno-associated virus serotype 5 revealed by high-throughput sequencing","volume":"88","author":"Janovitz","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1743-422X-11-15","article-title":"Adeno-associated virus type 2 preferentially integrates single genome copies with defined breakpoints","volume":"11","author":"Janovitz","year":"2014","journal-title":"Virol. J."},{"key":"10.1016\/j.omta.2026.201770_bib22","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1016\/j.jtha.2024.07.012","article-title":"Adeno-associated viral vector integration: implications for long-term efficacy and safety","volume":"22","author":"Batty","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.omta.2026.201770_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.omtm.2017.07.003","article-title":"Thermal Stability as a Determinant of AAV Serotype Identity","volume":"6","author":"Bennett","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201770_bib24","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1099\/0022-1317-83-5-973","article-title":"The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity","volume":"83","author":"Girod","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib7","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1128\/JVI.02093-13","article-title":"Adeno-associated virus capsid proteins may play a role in transcription and second-strand synthesis of recombinant genomes","volume":"88","author":"Salganik","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib25","doi-asserted-by":"crossref","first-page":"7196","DOI":"10.1128\/JVI.00493-16","article-title":"Mutants at the 2-Fold Interface of Adeno-associated Virus Type 2 (AAV2) Structural Proteins Suggest a Role in Viral Transcription for AAV Capsids","volume":"90","author":"Aydemir","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib26","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI66611","article-title":"Adeno-associated virus capsid antigen presentation is dependent on endosomal escape","volume":"123","author":"Li","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omta.2026.201770_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2013.9","article-title":"Empty Virions In AAV8 Vector Preparations Reduce Transduction Efficiency And May Cause Total Viral Particle Dose-Limiting Side-Effects","volume":"1","author":"Gao","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201770_bib28","doi-asserted-by":"crossref","first-page":"29745","DOI":"10.1074\/jbc.273.45.29745","article-title":"The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton","volume":"273","author":"Fanning","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201770_bib29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.coph.2014.07.017","article-title":"Molecular aspects of tight junction barrier function","volume":"19","author":"Liang","year":"2014","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.omta.2026.201770_bib30","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3390\/pathogens11101200","article-title":"Tight Junctions, the Key Factor in Virus-Related Disease","volume":"11","author":"Ding","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.omta.2026.201770_bib31","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/mt.2011.72","article-title":"Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates","volume":"19","author":"Gray","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201770_bib32","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13861","article-title":"Trafficking of adeno-associated virus vectors across a model of the blood-brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells","volume":"140","author":"Merkel","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.omta.2026.201770_bib33","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1099\/vir.0.2008\/001446-0","article-title":"Transient cytochalasin-D treatment induces apically administered rAAV2 across tight junctions for transduction of enterocytes","volume":"89","author":"Fu","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib34","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1128\/JVI.72.2.1438-1445.1998","article-title":"Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions","volume":"72","author":"Summerford","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib35","doi-asserted-by":"crossref","first-page":"11072","DOI":"10.1128\/JVI.77.20.11072-11081.2003","article-title":"Identification of a heparin-binding motif on adeno-associated virus type 2 capsids","volume":"77","author":"Kern","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib36","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1128\/JVI.77.12.6995-7006.2003","article-title":"Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding","volume":"77","author":"Opie","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib37","doi-asserted-by":"crossref","first-page":"11393","DOI":"10.1128\/JVI.01288-06","article-title":"Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes","volume":"80","author":"Wu","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib38","doi-asserted-by":"crossref","first-page":"8961","DOI":"10.1128\/JVI.00843-06","article-title":"Adeno-associated virus type 2 contains an integrin alpha5beta1 binding domain essential for viral cell entry","volume":"80","author":"Asokan","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/4758","article-title":"Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2","volume":"5","author":"Qing","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2026.201770_bib40","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/gt.2012.6","article-title":"Intracellular transport of recombinant adeno-associated virus vectors","volume":"19","author":"Nonnenmacher","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2026.201770_bib41","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1128\/JVI.74.6.2777-2785.2000","article-title":"Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors","volume":"74","author":"Bartlett","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib42","doi-asserted-by":"crossref","first-page":"10462","DOI":"10.1128\/JVI.00935-12","article-title":"Cytoplasmic trafficking, endosomal escape, and perinuclear accumulation of adeno-associated virus type 2 particles are facilitated by microtubule network","volume":"86","author":"Xiao","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib43","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/tpj.12134","article-title":"Microtubules in viral replication and transport","volume":"75","author":"Niehl","year":"2013","journal-title":"Plant J."},{"key":"10.1016\/j.omta.2026.201770_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/v12010117","article-title":"Microtubules in Influenza Virus Entry and Egress","volume":"12","author":"Simpson","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.omta.2026.201770_bib45","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00705-022-05366-1","article-title":"Virus interactions with the actin cytoskeleton-what we know and do not know about SARS-CoV-2","volume":"167","author":"Kloc","year":"2022","journal-title":"Arch. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1242\/jcs.102.3.401","article-title":"Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis","volume":"102","author":"Ann Jordan","year":"1992","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.omta.2026.201770_bib47","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/293302a0","article-title":"Cytochalasin D inhibits actin polymerization and induces depolymerization of actin filaments formed during platelet shape change","volume":"293","author":"Casella","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201770_bib49","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ymthe.2005.12.002","article-title":"rAAV2 traffics through both the late and the recycling endosomes in a dose-dependent fashion","volume":"13","author":"Ding","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201770_bib48","doi-asserted-by":"crossref","first-page":"9184","DOI":"10.1128\/JVI.74.19.9184-9196.2000","article-title":"Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation","volume":"74","author":"Sanlioglu","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib50","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrm2216","article-title":"Pathways of clathrin-independent endocytosis","volume":"8","author":"Mayor","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omta.2026.201770_bib51","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1146\/annurev.biochem.78.081307.110540","article-title":"Mechanisms of endocytosis","volume":"78","author":"Doherty","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.omta.2026.201770_bib52","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1128\/JVI.02393-05","article-title":"Gangliosides are essential for bovine adeno-associated virus entry","volume":"80","author":"Schmidt","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib53","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/mt.2016.49","article-title":"AAVR: A Multi-Serotype Receptor for AAV","volume":"24","author":"Summerford","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201770_bib54","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/12491","article-title":"Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2","volume":"5","author":"Girod","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2026.201770_bib55","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1006\/viro.1999.0045","article-title":"Insertional mutagenesis of AAV2 capsid and the production of recombinant virus","volume":"265","author":"Rabinowitz","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.omta.2026.201770_bib56","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1128\/JVI.74.18.8635-8647.2000","article-title":"Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism","volume":"74","author":"Wu","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib57","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1128\/JVI.02524-12","article-title":"Structure and dynamics of adeno-associated virus serotype 1 VP1-unique N-terminal domain and its role in capsid trafficking","volume":"87","author":"Venkatakrishnan","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib58","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/v12060668","article-title":"Adeno-Associated Virus (AAV) Capsid Stability and Liposome Remodeling During Endo\/Lysosomal pH Trafficking","volume":"12","author":"Lins-Austin","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.omta.2026.201770_bib59","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00843-21","article-title":"Adeno-associated Virus 9 Structural Rearrangements Induced by Endosomal Trafficking pH and Glycan Attachment","volume":"95","author":"Penzes","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib60","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1128\/JVI.75.4.1824-1833.2001","article-title":"Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation","volume":"75","author":"Douar","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib61","doi-asserted-by":"crossref","first-page":"11791","DOI":"10.1128\/JVI.05305-11","article-title":"Structural studies of adeno-associated virus serotype 8 capsid transitions associated with endosomal trafficking","volume":"85","author":"Nam","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib62","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1534-5807(01)00031-4","article-title":"A viral phospholipase A2 is required for parvovirus infectivity","volume":"1","author":"Z\u00e1dori","year":"2001","journal-title":"Dev. Cell"},{"key":"10.1016\/j.omta.2026.201770_bib63","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1128\/JVI.79.9.5296-5303.2005","article-title":"A conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1 N termini","volume":"79","author":"Kronenberg","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib64","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1128\/JVI.79.4.2528-2540.2005","article-title":"Mutational analysis of narrow pores at the fivefold symmetry axes of adeno-associated virus type 2 capsids reveals a dual role in genome packaging and activation of phospholipase A2 activity","volume":"79","author":"Bleker","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib65","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.3390\/v14091922","article-title":"Structural Dynamics and Activity of B19V VP1u during the pHs of Cell Entry and Endosomal Trafficking","volume":"14","author":"Lakshmanan","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.omta.2026.201770_bib66","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01604-20","article-title":"The Golgi Calcium ATPase Pump Plays an Essential Role in Adeno-associated Virus Trafficking and Transduction","volume":"94","author":"Madigan","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib67","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1006\/viro.1999.9664","article-title":"A 110-kDa nuclear shuttle protein, nucleolin, specifically binds to adeno-associated virus type 2 (AAV-2) capsid","volume":"257","author":"Qiu","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.omta.2026.201770_bib68","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1128\/jvi.71.2.1341-1352.1997","article-title":"Subcellular compartmentalization of adeno-associated virus type 2 assembly","volume":"71","author":"Wistuba","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib69","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1128\/JVI.02309-08","article-title":"Enhancement of adeno-associated virus infection by mobilizing capsids into and out of the nucleolus","volume":"83","author":"Johnson","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib70","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/19491034.2015.1079680","article-title":"Principles of protein targeting to the nucleolus","volume":"6","author":"Martin","year":"2015","journal-title":"Nucleus"},{"key":"10.1016\/j.omta.2026.201770_bib71","doi-asserted-by":"crossref","first-page":"9281","DOI":"10.1128\/JVI.74.19.9281-9293.2000","article-title":"Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection","volume":"74","author":"Wobus","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib74","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1064103","article-title":"Real-time single-molecule imaging of the infection pathway of an adeno-associated virus","volume":"294","author":"Seisenberger","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.omta.2026.201770_bib73","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.molmed.2020.09.010","article-title":"Journey to the Center of the Cell: Tracing the Path of AAV Transduction","volume":"27","author":"Dhungel","year":"2021","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.omta.2026.201770_bib75","doi-asserted-by":"crossref","first-page":"11040","DOI":"10.1128\/JVI.01056-06","article-title":"Adeno-associated virus type 2 capsids with externalized VP1\/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus","volume":"80","author":"Sonntag","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib76","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.tim.2021.09.005","article-title":"Adeno-associated virus (AAV) cell entry: structural insights","volume":"30","author":"Meyer","year":"2022","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.omta.2026.201770_bib77","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ymthe.2019.11.005","article-title":"GPR108 Is a Highly Conserved AAV Entry Factor","volume":"28","author":"Dudek","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201770_bib78","doi-asserted-by":"crossref","first-page":"11877","DOI":"10.1128\/JVI.01717-12","article-title":"Evidence for pH-dependent protease activity in the adeno-associated virus capsid","volume":"86","author":"Salganik","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib79","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ymthe.2006.05.009","article-title":"Adeno-associated virus serotypes: vector toolkit for human gene therapy","volume":"14","author":"Wu","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201770_bib80","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbrc.2012.06.063","article-title":"Cytochalasin D acts as an inhibitor of the actin-cofilin interaction","volume":"424","author":"Shoji","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omta.2026.201770_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010187","article-title":"Adeno-associated virus type 2 (AAV2) uncoating is a stepwise process and is linked to structural reorganization of the nucleolus","volume":"18","author":"Sutter","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omta.2026.201770_bib81","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1038\/s41467-021-21935-5","article-title":"Adeno-associated virus capsid assembly is divergent and stochastic","volume":"12","author":"W\u00f6rner","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201770_bib82","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","article-title":"Production of High-Titer Recombinant Adeno-Associated Virus Vectors in the Absence of Helper Adenovirus","volume":"72","author":"Xiao","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201770_bib83","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sj.gt.3300938","article-title":"Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield","volume":"6","author":"Zolotukhin","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2026.201770_bib84","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.omtm.2020.10.001","article-title":"Characterization of AAV-Specific Affinity Ligands: Consequences for Vector Purification and Development Strategies","volume":"19","author":"Mietzsch","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:17:12Z","timestamp":1789053432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X26001059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S3117387X26001059"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2026.201770","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracellular trafficking and nuclear compartmentalization of AAV gene delivery","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2026.201770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201770"}}